Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
Read more
UCB announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab...
Read more
Eli Lilly and Company announced that new results from a number of studies across the company's oncology product and pipeline...
Read more
Eli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic...
Read more
Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
Read more
Novartis announced the plan to initiate ARROW, a head-to-head proof of concept study to assess the mechanistic superiority of the...
Read more
Amgen announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
Read more
AstraZeneca and MedImmune, its global biologics research and development arm, announced high-level results from the Phase III ARCTIC trial in...
Read moreERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, announced the dosing of the...
Read more
Roche announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
